Document Classification

Section Type: RESULTS

Text: Among 483 patients (80. 3 % females, mean age 62. 1), the rofecoxib group vs the Arthrotec group respectively reported diarrhea 6. 2 % vs 16. 2 % (p < 0. 001) ; drug-related diarrhea 3. 7 % vs 16. 2 % (p < 0. 001) ; one or more clinical AEs 52. 9 % vs 73. 0 % (p < 0. 001) ; GI AEs 28. 9 % vs 48. 5 % (p < 0. 001) ; NSAID-type GI AEs 18. 6 % vs 29. 9 % (p = 0. 004) ; discontinuations due to abdominal pain 0. 4 % vs 3. 7 % (p < 0. 05) ; and discontinuations due to any AE 4. 1 % vs 9. 1 % (p = 0. 029).